Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 205,247,396 papers from all fields of science
Search
Sign In
Create Free Account
HER2/Neu Status
Known as:
ERBB2 Status
, Her2/Neu Value
The presence or absence of Her2/Neu on a tissue sample.
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Biomarkers for personalized oncology: recent advances and future challenges.
M. Kalia
Metabolism: clinical and experimental
2015
Corpus ID: 24795701
2011
2011
Synthesis of a covalent gemcitabine-(carbamate)-[anti-HER2/neu] immunochemotherapeutic and its cytotoxic anti-neoplastic activity against chemotherapeutic-resistant SKBr-3 mammary carcinoma.
C. Coyne
,
Toni Jones
,
T. Pharr
Bioorganic & medicinal chemistry
2011
Corpus ID: 32005115
2010
2010
Celecoxib and aromatase activity in breast cancer: Results from a prospective randomized preoperative trial.
E. Port
,
K. Subbaramaiah
,
+4 authors
C. Hudis
2010
Corpus ID: 73981037
1527 Background: COX-2 is overexpressed in many epithelial malignancies, including a subset of human breast cancers. Preclinical…
Expand
2009
2009
Changing Therapy as a Consequence of the Behaviour of CETC during Adjuvant Trastuzumab Treatment in Patients with Her2/Neu Positive Breast Cancer.
U. Hammer
,
O. Camara
,
K. Hekimian
,
A. Gellner
,
I. Runnebaum
,
K. Pachmann
2009
Corpus ID: 71895275
Gene silencing, demethylation, translocations and amplifications crucially contribute to the growth potential and aggressiveness…
Expand
2007
2007
[Overexpression and prognostic value of p53 and HER2/neu proteins in benign ovarian tissue and in ovarian cancer].
P. C. Coronado Martín
,
María Fasero Laiz
,
J. García Santos
,
Mar Ramírez Mena
,
J. A. Vidart Aragón
Medicina clinica
2007
Corpus ID: 6150403
BACKGROUND AND OBJECTIVE To investigate the prognostic value of p53 and HER2/neu overexpression in epithelial ovarian cancer (EOC…
Expand
2006
2006
Иммуноморфологическая характеристика процесса неоваскуляризации в метастазирующих аденокарциномах желудка с применением маркеров HER2/neu, Ki-67 и р53
В. Т. Зорькин
,
Ф. Лазарева
,
В. В. Климачёв
,
И. П. Бобров
,
А. М. Авдалян
2006
Corpus ID: 101410385
Highly Cited
2002
Highly Cited
2002
Differential gene expression patterns in HER2/neu-positive and -negative breast cancer cell lines and tissues.
K. S. Wilson
,
H. Roberts
,
R. Leek
,
A. Harris
,
J. Geradts
The American journal of pathology
2002
Corpus ID: 8544436
Review
1998
Review
1998
Comparative genomic hybridization analysis of sporadic neuroendocrine tumors of the digestive system
B. Terris
,
M. Meddeb
,
+5 authors
A. Bernheim
Genes, chromosomes & cancer
1998
Corpus ID: 23083089
Little information is available on the molecular mechanisms underlying neuroendocrine tumorigenesis. To obtain an overview of the…
Expand
Highly Cited
1993
Highly Cited
1993
Overexpression of HER2/neu oncogene in human pancreatic carcinoma.
Y. Yamanaka
,
H. Friess
,
+4 authors
M. Korc
Human pathology
1993
Corpus ID: 24366885
Highly Cited
1988
Highly Cited
1988
Sporadic amplification of the HER2/neu protooncogene in adenocarcinomas of various tissues.
M. Tal
,
M. Wetzler
,
+7 authors
J. Schlessinger
Cancer research
1988
Corpus ID: 37684080
The HER2/neu protooncogene was found to be amplified in 6 of 109 primary adenocarcinoma tumors. No HER2/neu amplification was…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE